DESAX
Price
$24.05
Change
+$0.18 (+0.75%)
Updated
Jul 3 closing price
Net Assets
262.61M
RWEBX
Price
$64.15
Change
+$0.53 (+0.83%)
Updated
Jul 3 closing price
Net Assets
202.05B
Interact to see
Advertisement

DESAX vs RWEBX

Header iconDESAX vs RWEBX Comparison
Open Charts DESAX vs RWEBXBanner chart's image
DWS ESG Core Equity A
Price$24.05
Change+$0.18 (+0.75%)
VolumeN/A
Net Assets262.61M
American Funds Washington Mutual R2E
Price$64.15
Change+$0.53 (+0.83%)
VolumeN/A
Net Assets202.05B
DESAX vs RWEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DESAX vs. RWEBX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DESAX is a Buy and RWEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 202B vs. DESAX (263M). RWEBX pays higher dividends than DESAX: RWEBX (0.80) vs DESAX (0.41). DESAX was incepted earlier than RWEBX: DESAX (20 years) vs RWEBX (11 years). RWEBX (1.06) is less costly to investors than DESAX (0.93). RWEBX is a more actively managed with annual turnover of: 31.00 vs. DESAX (9.00). RWEBX has a lower initial minimum investment than DESAX: RWEBX (250) vs DESAX (1000). RWEBX annual gain was more profitable for investors over the last year : 7.02 vs. DESAX (2.98). DESAX return over 5 years is better than : 68.93 vs. RWEBX (52.48).
DESAXRWEBXDESAX / RWEBX
Total Expense Ratio0.801.0675%
Annual Report Gross Expense Ratio0.931.0688%
Fund Existence20 years11 years-
Gain YTD4.9305.31993%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets263M202B0%
Annual Yield % from dividends0.410.8051%
Returns for 1 year2.987.0242%
Returns for 3 years49.4029.59167%
Returns for 5 years68.9352.48131%
Returns for 10 years35.8065.5655%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLK1.780.07
+4.09%
Outlook Therapeutics
GLRE14.320.17
+1.20%
Greenlight Capital Re Ltd
RGEN127.470.51
+0.40%
Repligen Corp
TGI25.820.09
+0.35%
Triumph Group
NUWE0.20-0.02
-10.57%
Nuwellis Inc